Robert Szulkin

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Demonstrating transportability of real-world evidence: what do HTA bodies and health technology developers need?

Demonstrating transportability of real-world evidence: what do HTA bodies and health technology developers need?

Journal: International journal of technology assessment in health care

Published: July 31, 2026

Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.

Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.

Journal: BJS open

Published: January 26, 2026

Association between shoulder joint radiation dose and arm morbidity in the randomized breast cancer trial SENOMAC.

Association between shoulder joint radiation dose and arm morbidity in the randomized breast cancer trial SENOMAC.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 13, 2026

Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study.

Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study.

Journal: European journal of haematology

Published: December 07, 2025

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study.

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study.

Journal: British journal of haematology

Published: February 03, 2025

Long-term risk of HCC in a DAA-treated national hepatitis C cohort, and a proposed risk score.

Long-term risk of HCC in a DAA-treated national hepatitis C cohort, and a proposed risk score.

Journal: Infectious diseases (London, England)

Published: September 25, 2024

Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast Cancer.

Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast Cancer.

Journal: JAMA surgery

Published: September 25, 2024

Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3).

Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3).

Journal: Cancer management and research

Published: August 09, 2024

Axillary clearance and chemotherapy rates in ER+HER2- breast cancer: secondary analysis of the SENOMAC trial.

Axillary clearance and chemotherapy rates in ER+HER2- breast cancer: secondary analysis of the SENOMAC trial.

Journal: The Lancet regional health. Europe

Published: June 30, 2024

Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial.

Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial.

Journal: The Lancet. Oncology

Published: April 14, 2024

Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.

Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.

Journal: The New England journal of medicine

Published: April 10, 2024

A population-based registry cohort study on the correlation between bladder-intact event-free survival and overall survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in Sweden.

A population-based registry cohort study on the correlation between bladder-intact event-free survival and overall survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in Sweden.

Journal: Scandinavian journal of urology

Published: February 09, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026